Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-493/ABT-530 in Asian adults with chronic HCV and compensated cirrhosis
CTR20170275Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of glecaprevir + pibrentasvir in hepatitis C virus infection, human immunodeficiency virus infection (HIV), sponsored by AbbVie Inc.. Started Jun 2017; status: completed.
02
Drugs
glecaprevir + pibrentasvir
03
Conditions
hepatitis C virus infectionhuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on CTR20170275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170275.